PAMS
IGMS

Pictet Asset Management (Switzerland)’s IGM Biosciences IGMS Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-934,965
Closed -$27.4M – 1711
2021
Q4 		$27.4M Buy
934,965
+350,618
+60% +$17.4M 0.03% 453
2021
Q3 		$38.4M Buy
+584,347
New +$44.7M 0.04% 385

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s IGMS Position: Q1 2022 in Review

Pictet Asset Management (Switzerland) sold out of IGM Biosciences (IGMS) in Q1 2022, closing a stake of 934,965 shares — an estimated $27.4M sold.

Pictet Asset Management (Switzerland) first reported a position in IGMS in Q3 2021 and held it in 2 quarters. The position peaked at $38.4M in Q3 2021. 93 funds tracked by Wall St. Rank hold IGMS as of Q1 2022.

  • Pictet Asset Management (Switzerland) reported no remaining IGM Biosciences position as of Q1 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 934,965 IGM Biosciences shares in Q1 2022, an estimated $27.4M.
  • Pictet Asset Management (Switzerland) first reported a position in IGM Biosciences in Q3 2021 and held it in 2 quarters.
  • Pictet Asset Management (Switzerland)'s IGM Biosciences position peaked at $38.4M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 13 May 2022.